FluLaval Approval History
- FDA approved: Yes (First approved October 5th, 2006)
- Brand name: FluLaval
- Generic name: Influenza Virus Vaccine
- Company: GlaxoSmithKline
- Treatment for: Influenza Prophylaxis
FluLaval (Influenza Virus Vaccine) is indicated for the active immunization of adults 18 years and older against influenza disease caused by influenza virus types A and B contained in the vaccine.
FDA Approval History for FluLaval
|Oct 5, 2006||FluLaval GlaxoSmithKline - Treatment for Prevention of Influenza|
|Mar 23, 2006||GlaxoSmithKline Submits Biologics License Application for FDA Approval of FluLaval|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.